Healthcare: Drug Reform Worries Are Overblown
March 29, 2016 at 08:00 AM EDT
Concern over unlikely U.S. drug pricing reforms has led to favorable valuations in healthcare.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.